These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 29258717

  • 1. Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells.
    Prasad S, Neef T, Xu D, Podojil JR, Getts DR, Shea LD, Miller SD.
    J Autoimmun; 2018 May; 89():112-124. PubMed ID: 29258717
    [Abstract] [Full Text] [Related]

  • 2. Genetic and therapeutic control of diabetogenic CD8+ T cells.
    Santamaria P.
    Novartis Found Symp; 2008 May; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
    [Abstract] [Full Text] [Related]

  • 3. Tolerance strategies employing antigen-coupled apoptotic cells and carboxylated PLG nanoparticles for the treatment of type 1 diabetes.
    Prasad S, Xu D, Miller SD.
    Rev Diabet Stud; 2012 May; 9(4):319-27. PubMed ID: 23804269
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nanoparticles Containing an Insulin-ChgA Hybrid Peptide Protect from Transfer of Autoimmune Diabetes by Shifting the Balance between Effector T Cells and Regulatory T Cells.
    Jamison BL, Neef T, Goodspeed A, Bradley B, Baker RL, Miller SD, Haskins K.
    J Immunol; 2019 Jul 01; 203(1):48-57. PubMed ID: 31109955
    [Abstract] [Full Text] [Related]

  • 12. APC-targeted proinsulin expression inactivates insulin-specific memory CD8+ T cells in NOD mice.
    Reeves PL, Rudraraju R, Liu X, Wong FS, Hamilton-Williams EE, Steptoe RJ.
    Immunol Cell Biol; 2017 Oct 01; 95(9):765-774. PubMed ID: 28611473
    [Abstract] [Full Text] [Related]

  • 13. Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading.
    Prasad S, Kohm AP, McMahon JS, Luo X, Miller SD.
    J Autoimmun; 2012 Dec 01; 39(4):347-53. PubMed ID: 22647732
    [Abstract] [Full Text] [Related]

  • 14. Multipeptide-coupled nanoparticles induce tolerance in 'humanised' HLA-transgenic mice and inhibit diabetogenic CD8+ T cell responses in type 1 diabetes.
    Xu X, Bian L, Shen M, Li X, Zhu J, Chen S, Xiao L, Zhang Q, Chen H, Xu K, Yang T.
    Diabetologia; 2017 Dec 01; 60(12):2418-2431. PubMed ID: 28887632
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice.
    Mukhopadhaya A, Hanafusa T, Jarchum I, Chen YG, Iwai Y, Serreze DV, Steinman RM, Tarbell KV, DiLorenzo TP.
    Proc Natl Acad Sci U S A; 2008 Apr 29; 105(17):6374-9. PubMed ID: 18430797
    [Abstract] [Full Text] [Related]

  • 20. Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice.
    Vincent BG, Young EF, Buntzman AS, Stevens R, Kepler TB, Tisch RM, Frelinger JA, Hess PR.
    J Immunol; 2010 Apr 15; 184(8):4196-204. PubMed ID: 20220085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.